INTUITIVE SURGICAL, INC.

(ISRG)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
238.37 USD   +1.00%
08/05INSIDER SELL : Intuitive Surgical
MT
08/02INTUITIVE SURGICAL INC : Other Events (form 8-K)
AQ
07/29INSIDER SELL : Intuitive Surgical
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Intuitive Surgical, Inc.(NasdaqGS:ISRG) added to Russell 3000 Value Index

06/24/2022 | 12:00am EDT

Intuitive Surgical, Inc.(NasdaqGS:ISRG) added to Russell 3000 Value Index


© S&P Capital IQ 2022
All news about INTUITIVE SURGICAL, INC.
08/05INSIDER SELL : Intuitive Surgical
MT
08/02INTUITIVE SURGICAL INC : Other Events (form 8-K)
AQ
07/29INSIDER SELL : Intuitive Surgical
MT
07/26WALL STREET STOCK EXCHANGE : Earnings bonanza
MS
07/26ANALYST RECOMMENDATIONS : Microsoft, UnitedHealth, American Express, EOG Resources, Haleon..
MS
07/25Goldman Sachs Adjusts Intuitive Surgical's Price Target to $273 From $319, Maintains Bu..
MT
07/22INTUITIVE SURGICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
07/22Truist Securities Adjusts Intuitive Surgical's Price Target to $255 from $270, Keeps Bu..
MT
07/22Raymond James Adjusts Price Target on Intuitive Surgical to $255 From $294, Keeps Outpe..
MT
07/22Citigroup Adjusts Price Target on Intuitive Surgical to $243 From $245, Reiterates Buy ..
MT
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2022 6 222 M - -
Net income 2022 1 403 M - -
Net cash 2022 1 710 M - -
P/E ratio 2022 62,1x
Yield 2022 -
Capitalization 85 125 M 85 125 M -
EV / Sales 2022 13,4x
EV / Sales 2023 11,7x
Nbr of Employees 9 793
Free-Float 99,5%
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 238,37 $
Average target price 251,29 $
Spread / Average Target 5,42%
EPS Revisions
Managers and Directors
Gary S. Guthart Chief Executive Officer & Director
Jamie E. Samath Chief Financial Officer & Senior Vice President
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Kara Andersen Reiter Assistant General Counsel
Sector and Competitors
1st jan.Capi. (M$)
INTUITIVE SURGICAL, INC.-33.66%85 125
THERMO FISHER SCIENTIFIC-9.60%236 331
DANAHER CORPORATION-9.50%216 597
EDWARDS LIFESCIENCES CORPORATION-19.10%64 970
BOSTON SCIENTIFIC CORPORATION-0.35%60 600
SIEMENS HEALTHINEERS AG-21.51%59 307